A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors
- PMID: 6288214
- DOI: 10.1002/1097-0142(19821015)50:8<1486::aid-cncr2820500807>3.0.co;2-f
A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors
Abstract
The basement membrane of basal cell carcinoma was characterized by indirect immunofluorescence using antibodies to laminin, type IV collagen, and bullous pemphigoid antigen, three distinct protein components of basement membrane. Aggregates of basal cell carcinoma in the dermis were surrounded by a continuous basement membrane containing laminin and type IV collagen; however, bullous pemphigoid antigen was either completely undetectable or faint and discontinuous rather than linear. In contrast to this specific defect in bullous pemphigoid antigen found in basal cell carcinoma, well-differentiated superficially invasive epidermal squamous cell carcinoma and several benign epidermal tumors (trichoepithelioma, wart, keratocanthoma, seborrheic keratosis, cylindroma) displayed all three antigens in the basement membrane that surrounded epithelial cell aggregates. Cylindroma displayed in addition, broad areas of type IV collagen in the hyalinized material between epithelial islands. Basal cell carcinoma was the only tumor examined in which there was a specific antigenic defect in the basement membrane. This defect in bullous pemphigoid antigen may be due to abnormal synthesis by the tumor cells and could be related to the absence of differentiation of these cells.
Similar articles
-
Loss of bullous pemphigoid antigen in peritumoral lacunas of basal cell carcinomas.Acta Derm Venereol. 1984;64(3):209-13. Acta Derm Venereol. 1984. PMID: 6204481
-
Antigenic alterations in tumors of epidermal origin.Cancer. 1980 May 1;45(9):2284-90. doi: 10.1002/1097-0142(19800501)45:9<2284::aid-cncr2820450911>3.0.co;2-s. Cancer. 1980. PMID: 7379027
-
A comparison of the expression of known basement membrane components with the linear IgA disease antigens using the novel substrate cylindroma.Br J Dermatol. 1999 Jul;141(1):62-70. doi: 10.1046/j.1365-2133.1999.02922.x. Br J Dermatol. 1999. PMID: 10417517
-
Defective expression of basement membrane-associated C3d,g in papulonodular basal cell carcinomas.J Invest Dermatol. 1989 May;92(5):734-8. doi: 10.1111/1523-1747.ep12721747. J Invest Dermatol. 1989. PMID: 2654297
-
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4. Clin Rev Allergy Immunol. 2018. PMID: 28779299 Review.
Cited by
-
Decreased anchoring-fibril antigens (AF1 and AF2) in basal-cell carcinoma.Arch Dermatol Res. 1985;277(6):499-501. doi: 10.1007/BF00510070. Arch Dermatol Res. 1985. PMID: 4051560 No abstract available.
-
Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases.Front Cell Dev Biol. 2019 May 7;7:68. doi: 10.3389/fcell.2019.00068. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31134198 Free PMC article. Review.
-
Lectin-binding abnormalities in the stromal and epithelial components of basal cell carcinoma.Br J Cancer. 1985 Jul;52(1):117-22. doi: 10.1038/bjc.1985.158. Br J Cancer. 1985. PMID: 2410002 Free PMC article. No abstract available.
-
Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma.Med Mol Morphol. 2019 Jun;52(2):99-105. doi: 10.1007/s00795-018-0207-x. Epub 2018 Oct 1. Med Mol Morphol. 2019. PMID: 30276677
-
Multimodal Considerations Concerning Basal Cell Carcinoma Clefting - Profile of Structural and Aggressive Traits - Perspectives.Clin Cosmet Investig Dermatol. 2022 Sep 29;15:2087-2095. doi: 10.2147/CCID.S385213. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36199384 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical